Allergic Bronchopulmonary Aspergillosis (ABPA) Panel
Also known as: ABPA
Use
The Allergic Bronchopulmonary Aspergillosis (ABPA) Panel is designed to aid in the diagnosis of ABPA, which is a condition characterized by a hypersensitivity reaction in the lungs to the fungus Aspergillus fumigatus. The condition is commonly associated with asthma and cystic fibrosis and can lead to lung damage if not diagnosed and treated effectively. This panel helps in assessing the immune response to Aspergillus fumigatus by measuring IgE levels and the presence of specific antibodies through various immunoassays.
Special Instructions
Not provided.
Limitations
The panel might not detect all cases of allergic bronchopulmonary aspergillosis, especially in early stages or when patients are immunocompromised. False positives can occur in patients with other types of fungal infections or significant mold exposure. Test precision is dependent on proper specimen handling and processing.
FDA ApprovedNew York Approved
Methodology
Immunoassay (Fluorescent Enzyme Immunoassay)
Biomarkers
LOINC Codes
- 19113-0 - IgE SerPl-aCnc
- 6025-1 - A fumgtus IgE Qn
- 6808-0 - A fumigatus1 Ab Ser Ql ID
- 6809-8 - A fumigatus6 Ab Ser Ql ID
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.3 mL
Minimum Volume
1 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells within 2 hours of collection.
Storage Instructions
Refrigerated
Causes for Rejection
Plasma. Hemolyzed, icteric or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant